Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Protagonist Therapeutics Inc (NQ: PTGX )

47.02 USD +0.20 (+0.43%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 23, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 336,157
Open 47.04
Bid (Size) 47.02 (1)
Ask (Size) 47.03 (57)
Prev. Close 46.82
Today's Range 45.55 - 47.88
52wk Range 14.16 - 48.70
Shares Outstanding 43,945,166
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Protagonist Therapeutics Reports Granting of Inducement Award
Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on June 30, 2021, it issued an inducement award to Patrick Smith, the Company's recently hired Vice President, Quality Assurance, in... 
From PR Newswire
Protagonist Therapeutics, Inc. Announces Closing of $132.2 Million Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
Protagonist Therapeutics, Inc. (Nasdaq:PTGX), a clinical stage biopharmaceutical company, today announced the closing of its previously announced underwritten public offering of 3,503,311 shares of its... 
From PR Newswire

Performance

YTD
+139.90%
+139.90%
1 Month
+8.67%
+8.67%
3 Month
+61.75%
+61.75%
6 Month
+110.29%
+110.29%
1 Year
+188.82%
+188.82%

More News

Read More
Protagonist Therapeutics Announces Pricing of $115 Million Upsized Public Offering of Common Stock
From PR Newswire
Interesting PTGX Put And Call Options For August 20th
Tags Stocks
From Market News Video
Protagonist Therapeutics Secures $115M Via Equity Raise
Tags Offerings Small Cap Biotech
From Benzinga
The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO
Tags ELEV Penny Stocks BHVN
From Benzinga
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
Tags SNOA OTIC ERYP
From Benzinga
Stocks That Hit 52-Week Highs On Tuesday
Tags PBH ORLY MAA
From Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
Tags RNAZ MYGN GMED
From Benzinga
The Daily Biotech Pulse: Iterum's Regulatory Setback, Decision Day For Provention Bio, Cidara & Outset Medical Announce CFO Departures
Tags BEAM Benzinga ZTS
From Benzinga
Stocks That Hit 52-Week Highs On Wednesday
Tags NVDA PTGX TWN
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.